Validity of the recorded codes of gonadotropin-releasing hormone agonist treatment and orchiectomies in the Danish National Patient Registry

Clinical Epidemiology

Volumn 4, Issue 1, 2012, Pages 145-149

  Jespersen, Christina Gade ^a   Borre, Michael ^a   Nørgaard, Mette ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Negative predictive value; Orchiectomy; Positive predictive value; Prostate cancer

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; DENMARK; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; ORCHIECTOMY; PATIENT CODING; PATIENT INFORMATION; PREDICTION; PROSTATE CANCER; VALIDATION STUDY; VALIDITY;

EID: 84863909269     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S32313     Document Type: Article

References (12)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.
2. Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR, CaPSURE. Time trends in clinical risk stratification for prostate cancer: Implications for outcomes (data from CaPSURE). J Urol. 2003;170(6 Pt 2):S21-S15; discussion S26-S27.
3. Uroweb. org. European Association of Urology: guidelines on prostate cancer, 2012. Available at: http://www.uroweb.org/gls/pdf/08%20Prostate%20Cancer_LR%20March%2013th%202012.pdf. Accessed May 14, 2012.
4. Keating NL, O'Malley AJ, Freedland SJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. J Natl Cancer Inst. 2010;102(1):39-46.
5. Saigal CS, Gore JL, Krupski TL, et al. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer. 2007;110(7):1493-1500.
6. Azoulay L, Yin H, Benayoun S, Renoux C, Boivin JF, Suissa S. Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur Urol. 2011;60(6):1244-1250.
7. Alibhai SM, Duong-Hua M, Sutradhar R, et al. Impact of androgen deprivation therapy on cardiovascular disease and diabetes. J Clin Oncol. 2009;27(21):3452-3458.
8. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287(5462):2398-2399.
9. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The danish cancer registry-history, content, quality and use. Dan Med Bull. 1997; 44(5):535-539.
10. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(Suppl 7):30-33.
11. Sorensen HT, Sabroe S, Olsen J. A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol. 1996;25(2):435-442.
12. Martin-Merino E, Johansson S, Morris T, Garcia Rodriguez LA. Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care. Drug Saf. 2011;34(11): 1061-1077.